| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.09 |